PharmaVoice 100: Page 5

  • A portrait of Kunal Ghosh framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kunal Ghosh
    Image attribution tooltip
    Profile // PharmaVoice 100

    Tech Wizards: Kunal Ghosh

    The leader of Inscopix embodies a 'bootstrap' approach to entrepreneurship, from soldering early versions of the Inscopix technology to taking a 'science-first' approach to fundraising.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of LaQuinta Jernigan framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by LaQuinta Jernigan
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: LaQuinta Jernigan

    The chief operating officer and ‘face’ of mdgroup is a leading voice in the efforts to diversify clinical trials.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Laura Niklason framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Laura Niklason
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Dr. Laura Niklason

    The founder, president and CEO of Humacyte is turning science fiction into regenerative medicine reality.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Laurent Levy framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Laurent Levy
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Laurent Levy

    Nanobiotix’s co-founder is applying the principles of nanophysics to fight cancer with a universal mechanism of action.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Laxmi Bonagiri framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Laxmi Bonagiri
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Laxmi Bonagiri

    EClinical Solutions’ VP of India operations is creating a path to increase the number of women in senior leadership roles while changing the course of diseases for millions.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Lisa Walters-Hoffert framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Lisa Walters-Hoffert
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Lisa Walters-Hoffert

    Daré Bioscience’s CFO and co-founder is determined to rapidly advance innovations in women’s health.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Lori Abrams framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Lori Abrams
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Lori Abrams

    The VP of patient advocacy and clinical research diversity at WCG is shaking up the trial space by shining a light on underserved populations.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Mark Goldberg framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Mark Goldberg
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Dr. Mark Goldberg

    The savvy clinical trials pro has built a global CRO by targeting the needs of the industry’s bustling biotech sector.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Mark Sullivan framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Mark Sullivan
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Mark Sullivan

    Medicines Development for Global Health’s founder is committed to eliminating neglected tropical diseases around the world.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Mary-Ann Etiebet framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Mary-Ann Etiebet
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Dr. Mary-Ann Etiebet

    Merck’s associate vice president of health equity is making DE&I a part of the pharma giant's day-to-day strategy.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Matt Clark framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Matt Clark
    Image attribution tooltip
    Profile // PharmaVoice 100

    Tech Wizards: Matt Clark

    X-Chem’s CEO has pioneered DNA-encoded libraries to revolutionize small molecule discovery.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Matt Walz framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Matt Walz
    Image attribution tooltip
    Profile // PharmaVoice 100

    Tech Wizards: Matt Walz

    The innovative CEO is driving global clinical trial enrollment with a novel approach for the industry.   

    By • Sept. 6, 2022
  • A portrait of Maureen Hennessey framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Maureen Hennessey
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Maureen Hennessey

    The senior vice president, director of value transformation at PRECISIONvalue is moving the needle on patient nonadherence challenges.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Mike Gladstone framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Mike Gladstone
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Mike Gladstone

    The global president of Pfizer's Inflammation and Immunology unit is unlocking his team’s potential to meet big goals against a promising pipeline.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Nancy Lurker framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Nancy Lurker
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Nancy Lurker

    The CEO of EyePoint Pharmaceuticals is positioning the company to fundamentally reshape how retinal diseases are treated.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Nekzad Shroff framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Nekzad Shroff
    Image attribution tooltip
    Profile // PharmaVoice 100

    Tech Wizards: Nekzad Shroff

    Considered one of the industry’s ‘most powerful minds,’ the VP of product management at Saama is developing digital solutions with impact.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Nello Mainolfi framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Nello Mainolfi
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Nello Mainolfi

    Kymera Therapeutics’ CEO is chasing untreated disease targets by advancing a game-changing technology.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Nina Wachsman framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Nina Wachsman
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Nina Wachsman

    The CEO and co-founder of Know Rare is on a mission to connect rare disease patients with researchers and clinical trials.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Otis Johnson framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Otis Johnson
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Otis Johnson

    Clario’s chief diversity, inclusion and sustainability officer is looking to improve clinical trial recruitment with a bottom-up approach that first focuses on internal hiring practices. 

    By Karissa Waddick • Sept. 6, 2022
  • A portrait of Dr. Penelope Manasco framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Penelope Manasco
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Dr. Penelope Manasco

    How the NIH-trained scientist and CEO of MANA RBM is charting a new way forward in conducting clinical trials.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Rachel Lenington framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Rachel Lenington
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Rachel Lenington

    Athira Pharma’s COO is striving to transform the landscape for patients with Alzheimer’s and other neurodegenerative diseases.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Rafael Amado framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Rafael Amado
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Dr. Rafael Amado

    Quiet, supportive and collaborative leadership have made the R&D leader a standout innovator for Allogene Therapeutics.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Rahul Ballal framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Rahul Ballal
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Rahul Ballal

    Imara’s CEO walks the walk when it comes to being a patient-first company by empowering his teams to lead important initiatives with far-ranging impact.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Raymond Stevens framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Raymond Stevens
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Raymond Stevens

    The longtime pioneer in new drug discovery methods and founder of Structure Therapeutics has leveraged innovative science for commercial success.

    By • Sept. 6, 2022
  • A portrait of Renata Campos framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Renata Campos
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Renata Campos

    Takeda's Growth and Emerging Markets Business Unit president is driving growth by doing what’s right for patients and her teams.

    By PharmaVoice staff • Sept. 6, 2022